Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stary

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Haematology and Blood Transfusion|January 1, 1989
Correlations of clinical and laboratory data for prognosis in childhood acute lymphoblastic leukemiaA Petrakova, J Stary, O Hrodek, et al.
Leukemia|May 28, 2005
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensityU Creutzig, D Reinhardt, S Diekamp, et al.
Bratislavske Lekarske Listy|June 9, 2001
The review of imported visceral leishmaniosis in the Czech RepublicP Chalupa, J Vanista, I Burget, et al.
European Journal of Gynaecological Oncology|April 1, 2004
Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapyT Mardesic, M Snajderova, L Sramkova, et al.
Haematologica|October 12, 2000
Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working GroupP Sedlácek, J Trka, J Zuna, et al.
Bone Marrow Transplantation|November 26, 2008
Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donorsP Sedlacek, E Mejstrikova, R Formankova, et al.
Leukemia|March 11, 2005
Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemiaM Vaskova, E Mejstrikova, T Kalina, et al.
Leukemia|March 10, 2001
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALLK Seeger, S Viehmann, D Buchwald, et al.
Leukemia|January 23, 2009
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoringM Zaliova, E Fronkova, K Krejcikova, et al.
Leukemia|April 29, 2005
TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALLE Fronkova, J Madzo, J Zuna, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Haematology and Blood Transfusion|January 1, 1989
Correlations of clinical and laboratory data for prognosis in childhood acute lymphoblastic leukemiaA Petrakova, J Stary, O Hrodek, et al.
Leukemia|May 28, 2005
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensityU Creutzig, D Reinhardt, S Diekamp, et al.
Bratislavske Lekarske Listy|June 9, 2001
The review of imported visceral leishmaniosis in the Czech RepublicP Chalupa, J Vanista, I Burget, et al.
European Journal of Gynaecological Oncology|April 1, 2004
Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapyT Mardesic, M Snajderova, L Sramkova, et al.
Haematologica|October 12, 2000
Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working GroupP Sedlácek, J Trka, J Zuna, et al.
Bone Marrow Transplantation|November 26, 2008
Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donorsP Sedlacek, E Mejstrikova, R Formankova, et al.
Leukemia|March 11, 2005
Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemiaM Vaskova, E Mejstrikova, T Kalina, et al.
Leukemia|March 10, 2001
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALLK Seeger, S Viehmann, D Buchwald, et al.
Leukemia|January 23, 2009
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoringM Zaliova, E Fronkova, K Krejcikova, et al.
Leukemia|April 29, 2005
TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALLE Fronkova, J Madzo, J Zuna, et al.
Pageof 7